Renal Denervation as a Complementary Treatment Option for Uncontrolled Arterial Hypertension: A Situation Assessment

Author:

Wagener Max1ORCID,Dolan Eamon2,Arnous Samer3,Galvin Joseph4,Murphy Andrew W.5ORCID,Casserly Ivan4,Eustace Joseph6,O’Connor Stephen7,McCreery Charles8,Shand James8,Wall Catherine9,Matiullah Saijad10,Sharif Faisal1ORCID

Affiliation:

1. University Hospital Galway, University of Galway, H91 TK33 Galway, Ireland

2. Stroke and Hypertension Unit, Connolly Hospital, D15 X40D Dublin, Ireland

3. University Hospital Limerick, V94 F858 Limerick, Ireland

4. The Mater Misericordiae University Hospital, D07 R2WY Dublin, Ireland

5. Turloughmore Medical Centre, University of Galway, H91 TK33 Galway, Ireland

6. University College Cork, T12 K8AF Cork, Ireland

7. St. James’s Hospital, D08 NHY1 Dublin, Ireland

8. St. Vincent’s University Hospital, D04 T6F4 Dublin, Ireland

9. Tallaght University Hospital, D24 NR0A Dublin, Ireland

10. University Hospital Waterford, X91 ER8E Waterford, Ireland

Abstract

Uncontrolled arterial hypertension is a major global health issue. Catheter-based renal denervation has shown to lower blood pressure in sham-controlled trials and represents a device-based, complementary treatment option for hypertension. In this situation assessment, the authors, who are practicing experts in hypertension, nephrology, general practice and cardiology in the Republic of Ireland, discuss the current evidence base for the BP-lowering efficacy and safety of catheter-based renal denervation with different modalities. Although important questions remain regarding the identification of responders, and long-term efficacy and safety of the intervention, renal denervation has the potential to provide much-needed help to address hypertension and its adverse consequences. The therapeutic approach needs to be multidisciplinary and personalised to take into account the perspective of patients and healthcare professionals in a shared decision-making process.

Funder

Medtronic Ireland Ltd.

Gottfried & Julia Bangerter-Rhyner Foundation, Switzerland

Science Foundation Ireland

Publisher

MDPI AG

Subject

General Medicine

Reference97 articles.

1. NCD Risk Factor Collaboration (NCD-RisC) (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet, 398, 957–980.

2. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: The Lancet Commission on hypertension;Olsen;Lancet,2016

3. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis;Ettehad;Lancet,2016

4. Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF;Kandzari;Catheter. Cardiovasc. Interv.,2021

5. Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories;Blaschke;Annu. Rev. Pharmacol. Toxicol.,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3